Dr. Rohan Ganguli, MD, FRCP(C)

Peer-Reviewed Articles 

 *PDFs are provided for personal use only.


Gorcynzski, P., Patel, H., & Ganguli, R. (2013). Evaluating the accuracy, quality, and readability of online physical activity, exercise, and sport information for people with schizophrenia. Mental Health and Physical Activity, 5, 95-99.

Janney, C.A., Ganguli, R., Richardson, C.R., Holleman, R.G., Tang, G., Cauley, J.A., & Kriska, A.M. (2013). Sedentary Behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST study). Schizophrenia Research, 145(1-3), 63-68.

Strassnig, M., Awerbuck, J., Ganguli, R. (2013). Diabetes resolution following discontinuation of a second-generation antipsychotic. Clinical Schizophrenia and Related Psychosis, 6(4), 202-203. 


Strassnig, M., Brar, J.S., & Ganguli, R. (2012). Health-related quality of life, adiposity, and sedintary behavior in patients with early schizophrenia: Preliminary studyDiabetes, Metabolic Syndrome, and Obesity: Targets in Therapy, 5, 389-394.

Kidd, S.A., Kaur Bajwa, J., McKenzie, K.J., Ganguli, R., & Haji Khamneh, B. (2012). Cognitive remediation for individuals with psychosis in a supportive education setting: A pilot study. Rehabilitation Research and Practice, 2012, 1-5.


Ganguli, R. (2011). Comorbidities of obesity in serious mental illness. Psychiatric Annals, 41(10), 469-472. 

Ganguli, R., Basu, R., Brar, J., Chang, C., & Garbut, R. (2011). Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole. Clinical Schizophrenia & Related Psychoses, 5(2), 75-79.  doi: 10.3371/CSRP.5.2.3

Ganguli, R., Strassnig, M. (2011). Prevention of metabolic syndrome in serious mental illness. Psychiatric Clinics of North America, 34(1), 109-125.

Strassnig, M., Brar, J.S., Ganguli, R. (2011). Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophrenia Research, 126(1-3), 103-109. doi: 10.1016/j.schres.2010.10.025.


Rotondi, A.J., Anderson, C.M., Haas, G.L., Back, S.M., Spring, M.B., Ganguli, R., Newhill, C., Rosenstock, J. (2010). Web-based psychoeducational intervention for persons with schizophrenia and their supporters: One-year outcomes. Psychiatric Services, 61(11), 1099-1105.


Ganguli, R. (2009). Importance of metabolic syndrome for South Asians. Asian Journal of. Psychiatry, 2( 3),  93-94.  doi: 10.1016/j.ajp.2009.08.00       


Ganguli, R., Brar, J.S., Jaspreet. S., Mahmoud, R., Berry, S.A., & Pandina, G.J. (2008). Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study. BMC Medicine, 6, 17.  PMID 18590519. 

Everett, A.,  Mahler, J., Biblin, J., Ganguli, R., & Mauer, B. (2008). Improving the health of mental health consumers: Effective policies and practices. International Journal of Mental Health, 37(2), 8-48.

Coley, K.C., Fabian, T.J., Kim, E., Ammerman, D.K., Scipio, T.M., Saul, M.I. (…) Ganguli, R. (2008). Predictors of aripiprazole treatment continuation in hospitalized patients. Journal of Clinical Psychiatry, 69,  Suppl 6:1393-1397.  doi:  eJ08M04205 [pii]  PMID  19012819

Amiel, J.M, Mangurian, C.V., Ganguli, R., & Newcomer, J.W. (2008). Addressing cardiometabolic risk during treatment with antipsychotic medications. Current Opinion in Psychiatry, 21(6), 613-618.    doi:  10.1097/YCO.0b013e328314b74b  00001504-200811000-00016 [pii]PMID  18852570 


Strassnig, M., Miewald, J., Keshavan, M., & Ganguli, R. (2007). Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One year analysis. Schizophrenia Research, 93, 90-98.  PMID 17478082  

Strassnig, M., Ganguli, R. (2007). Weight loss interventions for patients with schizophrenia.  Clinical Schizophrenia and Related Psychoses, 1, 43-53.  

Rotondi, A.J., Sinkule Haas, G., Spring, M.B., Litschge, C.M., Newhill, C., Ganguli, R., & Anderson, C.M. (2007). Designing websites for persons with cognitive deficits: Design and usability of a  psychoeducational intervention for persons with severe mental illness. Psychological Services, 3, 202-224.  doi: 10.1037/1541-1559.4.3.202

Ganguli, R., Vreeland, B., & Newcomer, J.W. (2007). Monitoring and managing weight gain in the mentally ill. Journal of Clinical Psychiatry, 68(6), e14.  PMID 17592901.

Ganguli, R. (2007). Behavioral therapy for weight loss in patients with schizophrenia. Journal of Clinical Psychiatry, 68(Suppl. 4), 19-25.  PMID 17539696.

Eack, S., Schooler. N., &  Ganguli, R. (2007). Gerard E. Hogarty: Combining science and humanism to improve the care of persons with schizophrenia. Schizophrenia Bulletin, 33(5), 1056-1062.  PMID 17617662


Strassnig, M., Brar, J.S., &  Ganguli, R. (2006). Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophrenia Research, 86, 269-275.  PMID 16859897 

Ganguli, R,. &  Strassnig, M. (2006). Are older antipsychotic drugs obsolete? [Editorial]. British Medical Journal, 332(7554), 1346-7.  PMID 16763227


Strassnig, M., Brar, J.S., &  Ganguli, R. (2005). Self reported body weight perception and dieting practices in community dwelling patients with schizophrenia. Schizophrenia Research, 75, 425-432.  PMID 15885533.

Strassnig, M., Brar, J.S., &  Ganguli, R. (2005). Dietary intake of patients with schizophrenia. Psychiatry, 2, 31-35.

Strassnig, M., Brar, J.S.,&  Ganguli, R. (2005). Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophrenia Research, 76, 343-351.   PMID 15949667

Rotondi, A..J., Haas, G.L., Anderson, C.M., Newhill, C.E., Spring, M.B., Ganguli, R., Gardner, W.B., Rosenstock, J.B., Rosenstock, J.B. (2005).  A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families:  Intervention and 3-month findings. Rehabilitation Psychology, 50, 325-336. doi:  10.1037/0090-5550.50.4.325

Ganguli, R., & Brar, J.S.  (2005). Increasing energy expenditure is important to enhance management of antipsychotic-associated weight gain. Journal of Clinical Psychiatry, 66, 951.       

Brar, J.S., Ganguli, R, Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. (2005).  Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.  Journal of Clinical Psychiatry, 66(2), 205-212.  PMID 15705006  


Deshpande, S.N.,  Bhatia, T.,  Wood, J.,  Brar, J.S., Thelma, B.K., Ganguli, R. (...) Nimgaonkar, V.L. (2004). Evaluation of familial influences on the course and severity of schizophrenia among US and Indian cases. Social Psychiatry & Psychiatric Epidemiology,  39(5), 369-74.  PMID 15133593


Strassnig, M., Brar, J.S., & Ganguli, R. (2003). Nutritional assessment of patients with schizophrenia: A preliminary study. Schizophrenia Bulletin, 29(2), 393-397. PMID  14552512

Strassnig, M., Brar. J.S., & Ganguli. R. (2003). Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophrenia Research, 62(1-2), 73-76.  PMID 12765746 

Levine, J., Chengappa, K.N.R., & Ganguli, R. (2003). Cytokine alterations in schizophrenia: treatment implications. Essential Psychopharmacology, 61, 201-205.


Ganguli, R., Singh, A., Bras, J.S., Carter, C., & Mintun, M. (2002). Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET study. Schizophrenia Research, 56, 241-247. PMID 12072173

Ganguli, R. (2002).  Rationale and strategies for switching antipsychotics. American Journal of Health System Pharmacies, 59, 22-26.  PMID 12455296


Mullen, B., Brar, J.S., Vagnucci, A.H., & Ganguli, R. (2001). Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. Schizophrenia Research, 48, 155-8.  doi:  S0920-9964(00)00061-X [pii]  PMID  11345946  

Levine, J., Chengappa, K.N.R., Pate,l A., Vagnucci, A., John, V., Brar, J.S., Chalasani, L., Parepally, H., & Ganguli, R. (2001). Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility. Journal of Psychiatric Practice, 7, 432-439.  doi:  00131746-200111000-00011 [pii]  PMID  15990558

Kane, J.M., Marder, S.R,. Schooler, N.R., Wirshing, W.C., Umbricht, D,. Baker, R.W., Wirshing, D.A., Safferman, A., Ganguli, R. (…) Borenstein, M. (2001). Clozapine and haloperidol in moderately refractory schizophrenia: A 6-month randomized and double-blind comparison. Archives of General Psychiatry, 58, 965-972.  doi:  yoa9127 [pii]  PMID  11576036

Ganguli, R., Brar, J.S., Ayrton, Z. (2001). Weight gain over four months in schizophrenia patients: A comparison of olanzapine and risperidone. Schizophrenia Research, 49, 261-7.  doi: S0920996400000803 [pii]  PMID  11356587


Book Chapters

Ganguli R., Cohn, T.,&  Faulkner, G. (2009). Behavioral treatments for weight management in schizophrenia. In J.M. Meyer & H.A. Nasrallah  (Eds.), Medical Illness and Schizophrenia, 2nd Ed. Washington DC: American Psychiatric Press, Inc.

Wright, P., Nimgaonkar, V., Ganguli, R., & Murray, R.M. (2000). HLA and Psychiatric Disease in HLA & Human Disease P. Wright & R. Murray, (Eds.). Academic Press. 

Keshavan, M.S., Reynolds, C.F., Houck, P., &  Ganguli, R. (1991). Reduced REM latency in schizophrenia:Pathophysiological mechanisms. In G. Racagni, N. Brunello & T. Fukuda (Eds.), Biological Psychiatry Amsterdam: Excerpta Medica.

Chengappa, K.N.R., Nimgaonkar, V.L., &  Ganguli, R. (1991). Immunological alterations. In M.S.Keshavan & G. Kennedy (Eds.), Drug Induced Dysfunction in Psychiatry  (311-324). New York: Hemisphere Publications.     

Rabin, B.S., Ganguli, R., Lysle, D., &  Cunnick, T. (1990). Interaction between the central nervoussystem and the immune system. In P.E. Bigazzi, G. Wick & K. Wicher (Eds.), Progress in Autoimmunity. New York: Marcel Dekker, Inc. 

Keshavan, M.S., &  Ganguli, R. (1990). The biology of schizophrenia.  In R. Pohl & S. Gershon (Eds.), The biological basis of psychiatric treatment. Basel: S. Karger and Co. 

Ganguli, R., Rabin, B.S., & Kelly, R.H. (1989). Multiple autoantibodies and autoimmune disease in schizophrenic patients: Evidence for an autoimmune pathogenesis. In J. Hadden, K. Masek & G. Nistico (Eds.), Interactions among CNS, neuroendocrine and immune systems. Rome: Pythagora Press. 

Ganguli, R., Rabin, B.S., Raghu, U., & Ulrich, R. (1987). Lymphocyte subpopulations in schizophrenics and normals and the effects of varying antipsychotic dosage. In E. Kurstak, J.Z. Lipowski & P.V. Morolov (Eds.), Viruses, immunity and mental illness. New York: Plenum Press.

Mezzich, J.E., Dow, J.T., Ganguli, R., Munetz, M., & Segal, M. (1986). Computerized initial and discharge evaluations. In J.E. Mezzich (Ed.), Clinical Care and Information Systems in Psychiatry Washington, DC: American Psychiatric Press.

Ganguli, R. (1985). Medical aspects. In M. Hersen (Ed.), Practice of inpatient behavior therapy: Clinical guide. New York: Grune & Stratton Inc.

Ganguli, R. (1983). Medical assessment. In M. Hersen, A.E. Kazdin &  A.S. Bellack (Eds.), Clinical psychology handbook. New York: Pergamon Press.

Ganguli, R. & Detre, T.P. (1981). Psychopharmacology and behavior therapy.  In L. Michelson, M. Hersen &  S.M. Turner (Eds.) Future perspectives in behavior therapy. New York: Plenum Press. 1981.

Mellor, C.S., &  Ganguli, R. (1979). Semiography of tremor in alcohol withdrawal. In: M. Galanter (Ed.), Currents in Alcoholism (Vol. 5, 207-212). New York: Grune & Stratton. PMID 755622